• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.营养基因组学疗法治疗丙型肝炎病毒诱导的脂肪性肝炎。
BMC Gastroenterol. 2010 May 20;10:49. doi: 10.1186/1471-230X-10-49.
2
Nutrigenomics and nutrigenetics of ω3 polyunsaturated fatty acids.ω3 多不饱和脂肪酸的营养基因组学与营养遗传学。
Prog Mol Biol Transl Sci. 2012;108:75-112. doi: 10.1016/B978-0-12-398397-8.00004-6.
3
Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.伴侣介导的自噬将IFNAR1靶向游离脂肪酸处理的丙型肝炎病毒细胞培养中的溶酶体降解。
PLoS One. 2015 May 11;10(5):e0125962. doi: 10.1371/journal.pone.0125962. eCollection 2015.
4
Lipid droplets and hepatitis C virus infection.脂滴与丙型肝炎病毒感染
Biochim Biophys Acta. 2009 Jun;1791(6):552-9. doi: 10.1016/j.bbalip.2008.12.012. Epub 2009 Jan 3.
5
Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.转化生长因子β在丙型肝炎病毒基因型特异性感染中作为脂生成途径的调节分子发挥作用。
J Virol. 2019 Aug 28;93(18). doi: 10.1128/JVI.00811-19. Print 2019 Sep 15.
6
Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication.复杂的脂质代谢重编程是丙型肝炎病毒复制所必需的。
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):1041-1056. doi: 10.1016/j.bbalip.2018.06.002. Epub 2018 Jun 6.
7
Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture.细胞培养中普通营养物质对丙型肝炎病毒RNA复制影响的综合分析。
Antimicrob Agents Chemother. 2007 Jun;51(6):2016-27. doi: 10.1128/AAC.01426-06. Epub 2007 Apr 9.
8
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.n-3 多不饱和脂肪酸治疗酒精性肝病:批判性评价。
Crit Rev Food Sci Nutr. 2019;59(sup1):S116-S129. doi: 10.1080/10408398.2018.1544542. Epub 2018 Dec 22.
9
Anti-HCV activities of selective polyunsaturated fatty acids.选择性多不饱和脂肪酸的抗丙型肝炎病毒活性。
Biochem Biophys Res Commun. 2004 May 21;318(1):275-80. doi: 10.1016/j.bbrc.2004.04.019.
10
Development of an in vitro model to study hepatitis C virus effects on hepatocellular lipotoxicity and lipid metabolism.开发一种体外模型以研究丙型肝炎病毒对肝细胞脂肪毒性和脂质代谢的影响。
Pathol Res Pract. 2018 Oct;214(10):1700-1706. doi: 10.1016/j.prp.2018.08.013. Epub 2018 Aug 19.

引用本文的文献

1
Antiviral activity of eicosapentaenoic acid against zika virus and other enveloped viruses.二十碳五烯酸对寨卡病毒及其他包膜病毒的抗病毒活性。
Front Pharmacol. 2025 Apr 4;16:1564504. doi: 10.3389/fphar.2025.1564504. eCollection 2025.
2
Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?营养保健品能否支持 MASLD/MASH 的治疗,从而影响肝纤维化的进程?
Int J Mol Sci. 2024 May 11;25(10):5238. doi: 10.3390/ijms25105238.
3
Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review.类胡萝卜素的营养重要性及其对肝脏健康的影响:综述
Antioxidants (Basel). 2019 Jul 19;8(7):229. doi: 10.3390/antiox8070229.
4
Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review.生物活性脂质在乙肝、丙肝及酒精性肝炎、非酒精性脂肪性肝病和肝硬化的病理生物学、预防及管理中的有益作用:综述
J Adv Res. 2018 Dec 21;17:17-29. doi: 10.1016/j.jare.2018.12.006. eCollection 2019 May.
5
Carotenoids and non-alcoholic fatty liver disease.类胡萝卜素与非酒精性脂肪性肝病
Hepatobiliary Surg Nutr. 2015 Jun;4(3):161-71. doi: 10.3978/j.issn.2304-3881.2015.01.11.
6
Biologically active substances-enriched diet regulates gonadotrope cell activation pathway in liver of adult and old rats.富含生物活性物质的饮食调节成年和老年大鼠肝脏中的促性腺激素细胞激活途径。
Genes Nutr. 2014 Sep;9(5):427. doi: 10.1007/s12263-014-0427-1. Epub 2014 Aug 26.
7
Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: relationship with interleukin-6.花生四烯酸与长链 ω-3 脂肪酸比值升高可预测干扰素-α治疗后抑郁症的发生:与白细胞介素-6 的关系。
Brain Behav Immun. 2013 Jul;31:48-53. doi: 10.1016/j.bbi.2012.08.007. Epub 2012 Aug 19.

本文引用的文献

1
Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice.丙型肝炎病毒蛋白在转基因小鼠中诱导脂肪生成和甘油三酯分泌缺陷。
J Biol Chem. 2009 Nov 27;284(48):33466-74. doi: 10.1074/jbc.M109.019810. Epub 2009 Oct 6.
2
Nutrigenomics and gut health: meeting report from an international conference in Auckland, New Zealand, April 30, May 1-3, 2006.营养基因组学与肠道健康:2006年4月30日至5月1 - 3日在新西兰奥克兰举行的国际会议会议报告
Genes Nutr. 2007 Oct;2(1):157-60. doi: 10.1007/s12263-007-0046-1.
3
Uncoupling gene-diet interactions in inflammatory bowel disease (IBD).解开炎症性肠病(IBD)中基因与饮食的相互作用。
Genes Nutr. 2007 Oct;2(1):71-3. doi: 10.1007/s12263-007-0012-y.
4
An introduction to nutrigenomics developments and trends.营养基因组学的发展与趋势介绍。
Genes Nutr. 2007 Oct;2(1):11-3. doi: 10.1007/s12263-007-0011-z.
5
The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.饮食对丙型肝炎病毒相关慢性肝炎患者肝纤维化及干扰素治疗反应的影响。
Am J Gastroenterol. 2008 Dec;103(12):3159-66. doi: 10.1111/j.1572-0241.2008.02159.x. Epub 2008 Sep 11.
6
Dietary polyunsaturated fatty acids (C18:2 omega6 and C18:3 omega3) do not suppress hepatic lipogenesis.膳食多不饱和脂肪酸(C18:2 ω6和C18:3 ω3)不会抑制肝脏脂肪生成。
Biochim Biophys Acta. 2008 Aug;1781(8):406-14. doi: 10.1016/j.bbalip.2008.06.010. Epub 2008 Jul 4.
7
The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products.PPAR 配体在控制生长相关基因表达中的作用及其与脂质过氧化产物的相互作用。
PPAR Res. 2008;2008:524671. doi: 10.1155/2008/524671.
8
Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters.膳食多不饱和脂肪酸对过氧化物酶体ABC转运蛋白表达的影响。
Biochimie. 2008 Oct;90(10):1602-7. doi: 10.1016/j.biochi.2008.05.022. Epub 2008 Jun 10.
9
Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C.肥胖和脂肪变性影响慢性丙型肝炎患者的血清及肝脏炎症标志物。
Hepatology. 2008 Jul;48(1):80-7. doi: 10.1002/hep.22311.
10
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.过氧化物酶体增殖物激活受体(PPAR)调节剂与代谢紊乱
PPAR Res. 2008;2008:679137. doi: 10.1155/2008/679137.

营养基因组学疗法治疗丙型肝炎病毒诱导的脂肪性肝炎。

Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.

机构信息

Department of Endocrinology, Tenth People's Hospital, Tongji University, Shanghai 200072, China.

出版信息

BMC Gastroenterol. 2010 May 20;10:49. doi: 10.1186/1471-230X-10-49.

DOI:10.1186/1471-230X-10-49
PMID:20487553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2896340/
Abstract

Nutrigenomics is a relatively new branch of nutrition science, which aim is to study the impact of the foods we eat on the function of our genes. Hepatosteatosis is strongly associated with hepatitis C virus infection, which is known to increase the risk of the disease progression and reduce the likelihood of responding to anti- virus treatment. It is well documented that hepatitis C virus can directly alter host cell lipid metabolism through nuclear transcription factors. To date, only a limited number of studies have been on the effect of human foods on the nuclear transcription factors of hepatitis C virus -induced hepatosteatosis.Three nutrients, selected among 46 different nutrients: beta-carotene, vitamin D2, and linoleic acid were found in a cell culture system to inhibit hepatitis C virus RNA replication. In addition, polyunsaturated fatty acids (PUFAs) especially arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) have been demonstrated to inhibit hepatitis C virus RNA replication. These PUFAs, in particular the highly unsaturated n-3 fatty acids change the gene expression of PPARa and SREBP, suppress the expression of mRNAs encoding key metabolic enzymes and hereby suppress hepatic lipogenesis and triglyceride synthesis, as well as secretion and accumulation in tissues. A recent prospective clinical trial of 1,084 chronic hepatitis C patients compared to 2,326 healthy subjects suggests that chronic hepatitis C patients may benefit from strict dietary instructions.Increasing evidence suggest that some crucial nuclear transcription factors related to hepatitis C virus -associated hepatosteatosis and hepatitis C virus RNA itself can be controlled by specific anti- hepatitis C virus nutrition. It seems important that these findings are taken into account and specific nutritional supplements developed to be used in combination with interferon as adjunctive therapy with the aim to improve both the early as well as the sustained virological response.

摘要

营养基因组学是营养科学的一个相对较新的分支,其目的是研究我们所吃的食物对我们基因功能的影响。肝脂肪变性与丙型肝炎病毒感染密切相关,已知丙型肝炎病毒感染会增加疾病进展的风险,并降低对抗病毒治疗的反应可能性。有充分的文献记载表明,丙型肝炎病毒可以通过核转录因子直接改变宿主细胞的脂质代谢。迄今为止,只有少数研究关注人类食物对丙型肝炎病毒诱导的肝脂肪变性的核转录因子的影响。

在细胞培养系统中,选择了 46 种不同营养素中的三种营养素(β-胡萝卜素、维生素 D2 和亚油酸),发现它们可以抑制丙型肝炎病毒 RNA 的复制。此外,多不饱和脂肪酸(PUFA),特别是花生四烯酸(AA)、二十二碳六烯酸(DHA)和二十碳五烯酸(EPA),已被证明可以抑制丙型肝炎病毒 RNA 的复制。这些 PUFAs,特别是高度不饱和的 n-3 脂肪酸,改变了 PPARa 和 SREBP 的基因表达,抑制了编码关键代谢酶的 mRNA 的表达,从而抑制了肝内脂肪生成和甘油三酯的合成,以及在组织中的分泌和积累。最近对 1084 例慢性丙型肝炎患者和 2326 例健康对照者进行的前瞻性临床研究表明,慢性丙型肝炎患者可能受益于严格的饮食指导。越来越多的证据表明,一些与丙型肝炎病毒相关的肝脂肪变性和丙型肝炎病毒 RNA 本身相关的关键核转录因子可以通过特定的抗丙型肝炎病毒营养来控制。似乎重要的是,这些发现需要被考虑到,并开发出特定的营养补充剂,与干扰素联合使用作为辅助治疗,以提高早期和持续的病毒学应答。